首页 > 最新文献

Health sciences review (Oxford, England)最新文献

英文 中文
Challenges and opportunities in precision therapy for diabetic patients 糖尿病患者精准治疗的挑战与机遇
Pub Date : 2024-07-02 DOI: 10.1016/j.hsr.2024.100190

Diabetes, a chronic condition characterized by an inability to maintain normal glucose levels significantly accounts for enhancing the cost of healthcare expenditure. Managing diabetes using a standard medication protocol more often leads to progressive failure in effectively treating the associated complications. The recent trends involve understanding of diabetes's genetic architecture and its consequences have provided the background for application of precision medicine for customizing protocols for preventing and managing the diabetes therapy. Further, utilizing the electronic health data and genetic information for assisting care and planning therapeutic protocol for monogenic form of diabetes is well-executed example of genomic medicine. The present write-up emphasized recent advances about the causes and effects of diabetes genetics. This also drive to the need for the further investigation for ensuring the appropriate knowledge to enable patients and healthcare providers to make informed decisions for obtaining the best possible outcome.

糖尿病是一种以无法维持正常血糖水平为特征的慢性疾病,大大增加了医疗保健支出的成本。使用标准药物方案治疗糖尿病,往往无法有效治疗相关并发症。最近的趋势涉及对糖尿病基因结构及其后果的了解,这为应用精准医疗来定制预防和管理糖尿病治疗方案提供了背景。此外,利用电子健康数据和遗传信息来协助护理和规划单基因糖尿病的治疗方案,也是基因组医学的典范。本文强调了有关糖尿病遗传学原因和影响的最新进展。这也促使人们需要进一步调查,以确保获得适当的知识,使患者和医疗服务提供者能够做出明智的决定,以获得尽可能好的结果。
{"title":"Challenges and opportunities in precision therapy for diabetic patients","authors":"","doi":"10.1016/j.hsr.2024.100190","DOIUrl":"10.1016/j.hsr.2024.100190","url":null,"abstract":"<div><p>Diabetes, a chronic condition characterized by an inability to maintain normal glucose levels significantly accounts for enhancing the cost of healthcare expenditure. Managing diabetes using a standard medication protocol more often leads to progressive failure in effectively treating the associated complications. The recent trends involve understanding of diabetes's genetic architecture and its consequences have provided the background for application of precision medicine for customizing protocols for preventing and managing the diabetes therapy. Further, utilizing the electronic health data and genetic information for assisting care and planning therapeutic protocol for monogenic form of diabetes is well-executed example of genomic medicine. The present write-up emphasized recent advances about the causes and effects of diabetes genetics. This also drive to the need for the further investigation for ensuring the appropriate knowledge to enable patients and healthcare providers to make informed decisions for obtaining the best possible outcome.</p></div>","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772632024000436/pdfft?md5=91c275318bee0cf82e54dd8d44d869cd&pid=1-s2.0-S2772632024000436-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141638288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeted therapy for Chronic Obstructive Pulmonary Disease: Dupilumab's role in patients with elevated eosinophils 慢性阻塞性肺病的靶向治疗:杜匹单抗在嗜酸性粒细胞升高患者中的作用
Pub Date : 2024-07-02 DOI: 10.1016/j.hsr.2024.100189
Muzamil Akhtar , Mehmood Akhtar
{"title":"Targeted therapy for Chronic Obstructive Pulmonary Disease: Dupilumab's role in patients with elevated eosinophils","authors":"Muzamil Akhtar ,&nbsp;Mehmood Akhtar","doi":"10.1016/j.hsr.2024.100189","DOIUrl":"https://doi.org/10.1016/j.hsr.2024.100189","url":null,"abstract":"","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772632024000424/pdfft?md5=cd635a3905357fab4960c372a45f9318&pid=1-s2.0-S2772632024000424-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141582683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of rate of nicotine metabolism, as measured by the nicotine metabolite ratio (NMR), on smoking behaviours during pregnancy: A scoping review 以尼古丁代谢物比值(NMR)衡量的尼古丁代谢率对孕期吸烟行为的影响:范围界定综述
Pub Date : 2024-06-30 DOI: 10.1016/j.hsr.2024.100186
Min-Tz Weng , Angela Ratsch , Jared A Miles , Qiuda Zheng , Kathryn J Steadman

Smoking during pregnancy is detrimental to the foetus and the mother, but quitting smoking can be challenging for pregnant women. The nicotine metabolite ratio (NMR), the ratio between 3-hydroxycotinine and cotinine, indicates the rate of nicotine metabolism and is associated with smoking behaviours and cessation success in the general population. Our goal was to establish what is currently known about the rate of nicotine metabolism during pregnancy. A search was conducted from inception to January 2024 using PubMed, EMBASE, CINAHL, PsycINFO, Web of Science, and Medline. Inclusion criteria encompassed pregnant women actively using any tobacco or nicotine-containing products for whom cotinine and 3-hydroxycotinine levels were assessed in maternal saliva, blood, or urine samples. Exclusion criteria comprised non-English articles, passive exposure to smoking, and absence of cotinine and 3-hydroxycotinine measurements. In half of the studies, more than 75% of participants were White. Four studies demonstrated that NMR (i.e. rate of nicotine metabolism) increased during pregnancy. Two studies found opioid use can increase NMR, and higher NMR correlated with greater nicotine dependence during pregnancy. One study found that higher NMR was associated with heavy cigarette use during pregnancy. Similarly, one study revealed pregnant women with higher NMR are less likely to quit smoking. However, one study linked lower NMR to lower birth weight, particularly among African-American populations compared to White populations. NMR tends to increase during pregnancy, complicating smoking cessation. Although race is an important determinant of NMR, the limited range of ethnic backgrounds highlights a need for further research in diverse populations.

怀孕期间吸烟对胎儿和母亲都不利,但戒烟对孕妇来说是一项挑战。尼古丁代谢物比值(NMR),即3-羟基可替宁和可替宁之间的比值,表示尼古丁的代谢率,与一般人群的吸烟行为和戒烟成功率有关。我们的目标是确定目前已知的孕期尼古丁代谢率。我们使用 PubMed、EMBASE、CINAHL、PsycINFO、Web of Science 和 Medline 进行了从开始到 2024 年 1 月的检索。纳入标准包括积极使用任何烟草或含尼古丁产品的孕妇,并对孕妇唾液、血液或尿液样本中的可替宁和 3-羟基可替宁水平进行了评估。排除标准包括非英语文章、被动吸烟以及未进行可替宁和 3-羟基可替宁测量。在半数研究中,75% 以上的参与者为白人。四项研究表明,NMR(即尼古丁代谢率)在怀孕期间有所增加。两项研究发现,使用阿片类药物会增加 NMR,而较高的 NMR 与孕期尼古丁依赖性较高有关。一项研究发现,较高的 NMR 与孕期大量吸烟有关。同样,一项研究显示,NMR 较高的孕妇不太可能戒烟。不过,一项研究将较低的 NMR 与较低的出生体重联系在一起,尤其是非裔美国人与白人相比。在怀孕期间,NMR 往往会增加,从而使戒烟变得更加复杂。虽然种族是决定 NMR 的一个重要因素,但种族背景的范围有限,这凸显了在不同人群中开展进一步研究的必要性。
{"title":"The impact of rate of nicotine metabolism, as measured by the nicotine metabolite ratio (NMR), on smoking behaviours during pregnancy: A scoping review","authors":"Min-Tz Weng ,&nbsp;Angela Ratsch ,&nbsp;Jared A Miles ,&nbsp;Qiuda Zheng ,&nbsp;Kathryn J Steadman","doi":"10.1016/j.hsr.2024.100186","DOIUrl":"https://doi.org/10.1016/j.hsr.2024.100186","url":null,"abstract":"<div><p>Smoking during pregnancy is detrimental to the foetus and the mother, but quitting smoking can be challenging for pregnant women. The nicotine metabolite ratio (NMR), the ratio between 3-hydroxycotinine and cotinine, indicates the rate of nicotine metabolism and is associated with smoking behaviours and cessation success in the general population. Our goal was to establish what is currently known about the rate of nicotine metabolism during pregnancy. A search was conducted from inception to January 2024 using PubMed, EMBASE, CINAHL, PsycINFO, Web of Science, and Medline. Inclusion criteria encompassed pregnant women actively using any tobacco or nicotine-containing products for whom cotinine and 3-hydroxycotinine levels were assessed in maternal saliva, blood, or urine samples. Exclusion criteria comprised non-English articles, passive exposure to smoking, and absence of cotinine and 3-hydroxycotinine measurements. In half of the studies, more than 75% of participants were White. Four studies demonstrated that NMR (i.e. rate of nicotine metabolism) increased during pregnancy. Two studies found opioid use can increase NMR, and higher NMR correlated with greater nicotine dependence during pregnancy. One study found that higher NMR was associated with heavy cigarette use during pregnancy. Similarly, one study revealed pregnant women with higher NMR are less likely to quit smoking. However, one study linked lower NMR to lower birth weight, particularly among African-American populations compared to White populations. NMR tends to increase during pregnancy, complicating smoking cessation. Although race is an important determinant of NMR, the limited range of ethnic backgrounds highlights a need for further research in diverse populations.</p></div>","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772632024000394/pdfft?md5=b735b2d48bc89c954adf1cc8f39be48d&pid=1-s2.0-S2772632024000394-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141540873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transforming pediatric speech and language disorder diagnosis and therapy: The evolving role of artificial intelligence 改变儿科言语和语言障碍的诊断与治疗:人工智能不断发展的作用
Pub Date : 2024-06-24 DOI: 10.1016/j.hsr.2024.100188
Ankur Bhardwaj , Mridul Sharma , Sahil Kumar , Sumit Sharma , Prabodh Chander Sharma

Integrating artificial intelligence (AI) with healthcare offers a viable way to treat difficult issues like children's speech-sound disorder (SSD).AAC, or augmentative alternative communication, has shown great promise in helping people with SSD, and AI-driven methods hold even more promise for improving diagnosis and therapy. This review paper explores the synergy of AI, ML, and AAC in pediatric speech and language impairments. It also highlights current developments and potential future directions. Healthcare providers can improve communication outcomes for kids with speech impairments, increase early detection, and provide personalised therapy by utilizing AI and ML techniques. In addition to encouraging parental involvement, the combination of AI and AAC technologies spurs advancements in speech therapy applications. AI has the potential to transform healthcare and improve the quality of life for people with speech and language problems as it develops and works in tandem with medical knowledge.

将人工智能(AI)与医疗保健相结合,为治疗儿童言语-声音障碍(SSD)等疑难问题提供了一种可行的方法。AAC(即辅助替代交流)在帮助言语-声音障碍患者方面已显示出巨大的前景,而人工智能驱动的方法在改善诊断和治疗方面前景更为广阔。本综述论文探讨了人工智能、ML 和 AAC 在儿科言语和语言障碍中的协同作用。它还重点介绍了当前的发展情况和潜在的未来方向。医疗保健提供商可以利用人工智能和 ML 技术改善有语言障碍的儿童的沟通效果,提高早期检测率,并提供个性化治疗。除了鼓励家长参与外,人工智能和 AAC 技术的结合还能促进语言治疗应用的进步。随着人工智能的发展和与医学知识的结合,它有可能改变医疗保健,改善有语言障碍的人的生活质量。
{"title":"Transforming pediatric speech and language disorder diagnosis and therapy: The evolving role of artificial intelligence","authors":"Ankur Bhardwaj ,&nbsp;Mridul Sharma ,&nbsp;Sahil Kumar ,&nbsp;Sumit Sharma ,&nbsp;Prabodh Chander Sharma","doi":"10.1016/j.hsr.2024.100188","DOIUrl":"https://doi.org/10.1016/j.hsr.2024.100188","url":null,"abstract":"<div><p>Integrating artificial intelligence (AI) with healthcare offers a viable way to treat difficult issues like children's speech-sound disorder (SSD).AAC, or augmentative alternative communication, has shown great promise in helping people with SSD, and AI-driven methods hold even more promise for improving diagnosis and therapy. This review paper explores the synergy of AI, ML, and AAC in pediatric speech and language impairments. It also highlights current developments and potential future directions. Healthcare providers can improve communication outcomes for kids with speech impairments, increase early detection, and provide personalised therapy by utilizing AI and ML techniques. In addition to encouraging parental involvement, the combination of AI and AAC technologies spurs advancements in speech therapy applications. AI has the potential to transform healthcare and improve the quality of life for people with speech and language problems as it develops and works in tandem with medical knowledge.</p></div>","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772632024000412/pdfft?md5=c864e0a389ace1998e31ba275221792d&pid=1-s2.0-S2772632024000412-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141582961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transforming multidrug-resistant tuberculosis care: The potentials of telemedicine in resource-limited settings 转变耐多药结核病护理:远程医疗在资源有限环境中的潜力
Pub Date : 2024-06-24 DOI: 10.1016/j.hsr.2024.100185
David B. Olawade , Judith Eberhardt , Aanuoluwapo Clement David-Olawade , Malik A. Balogun , Obasanjo A. Bolarinwa , Deborah T. Esan

Multidrug-resistant tuberculosis (MDR-TB) is a significant public health challenge in low-resource settings owing to limited healthcare access and quality. However, telemedicine can potentially improve healthcare delivery by overcoming geographical barriers. This comprehensive review aimed to provide an overview of the current trends in utilizing telemedicine for MDR-TB control in low-resource settings. A systematic literature search were conducted in PubMed and CINAHL electronic databases and Google Scholar search engine to identify relevant articles on telemedicine and MDR-TB control in low-resource settings. The selected articles were analyzed and synthesized to provide a comprehensive overview of telemedicine's current trends and applications in MDR-TB control. The review results shows that telemedicine allows remote screening and diagnosis, facilitating early detection and timely treatment, provides access to experts through teleconsultation, which ensures optimal treatment outcomes, fosters training and education of healthcare providers, and supports follow-up care through teleconsultation and remote monitoring. Furthermore, telemedicine integration with data collection methods could improve MDR-TB surveillance and intervention. Findings from this review show the potential of telemedicine to improve MDR-TB control and patient health in low-resource settings. This makes it a promising prevention and management option. However, successful implementation requires overcoming limitations such as connectivity, infrastructure, and cultural barriers. Telemedicine can considerably improve MDR-TB control and reduce disease burden in underserved populations by utilizing possibilities and addressing the challenges.

由于医疗服务的可及性和质量有限,耐多药结核病(MDR-TB)是低资源环境下的一项重大公共卫生挑战。然而,远程医疗可以克服地理障碍,改善医疗服务。本综述旨在概述当前在低资源环境中利用远程医疗控制 MDR-TB 的趋势。我们在 PubMed 和 CINAHL 电子数据库以及 Google Scholar 搜索引擎中进行了系统的文献检索,以确定有关远程医疗和低资源环境中 MDR-TB 控制的相关文章。对所选文章进行了分析和综合,以全面概述远程医疗在 MDR-TB 控制中的当前趋势和应用。综述结果表明,远程医疗可进行远程筛查和诊断,从而促进早期发现和及时治疗;通过远程会诊提供与专家接触的机会,从而确保最佳治疗效果;促进对医疗服务提供者的培训和教育;通过远程会诊和远程监测支持后续护理。此外,远程医疗与数据收集方法的整合可以改善对耐药结核病的监测和干预。本综述的研究结果表明,在资源匮乏的环境中,远程医疗具有改善 MDR-TB 控制和患者健康的潜力。这使其成为一种有前景的预防和管理选择。然而,成功实施远程医疗需要克服各种限制,如连接性、基础设施和文化障碍。通过利用各种可能性和应对各种挑战,远程医疗可以大大改善对服务不足人群的耐药结核病控制并减轻疾病负担。
{"title":"Transforming multidrug-resistant tuberculosis care: The potentials of telemedicine in resource-limited settings","authors":"David B. Olawade ,&nbsp;Judith Eberhardt ,&nbsp;Aanuoluwapo Clement David-Olawade ,&nbsp;Malik A. Balogun ,&nbsp;Obasanjo A. Bolarinwa ,&nbsp;Deborah T. Esan","doi":"10.1016/j.hsr.2024.100185","DOIUrl":"https://doi.org/10.1016/j.hsr.2024.100185","url":null,"abstract":"<div><p>Multidrug-resistant tuberculosis (MDR-TB) is a significant public health challenge in low-resource settings owing to limited healthcare access and quality. However, telemedicine can potentially improve healthcare delivery by overcoming geographical barriers. This comprehensive review aimed to provide an overview of the current trends in utilizing telemedicine for MDR-TB control in low-resource settings. A systematic literature search were conducted in PubMed and CINAHL electronic databases and Google Scholar search engine to identify relevant articles on telemedicine and MDR-TB control in low-resource settings. The selected articles were analyzed and synthesized to provide a comprehensive overview of telemedicine's current trends and applications in MDR-TB control. The review results shows that telemedicine allows remote screening and diagnosis, facilitating early detection and timely treatment, provides access to experts through teleconsultation, which ensures optimal treatment outcomes, fosters training and education of healthcare providers, and supports follow-up care through teleconsultation and remote monitoring. Furthermore, telemedicine integration with data collection methods could improve MDR-TB surveillance and intervention. Findings from this review show the potential of telemedicine to improve MDR-TB control and patient health in low-resource settings. This makes it a promising prevention and management option. However, successful implementation requires overcoming limitations such as connectivity, infrastructure, and cultural barriers. Telemedicine can considerably improve MDR-TB control and reduce disease burden in underserved populations by utilizing possibilities and addressing the challenges.</p></div>","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772632024000382/pdfft?md5=aefc45a9a91fc0b78cad95ea8b3c6833&pid=1-s2.0-S2772632024000382-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141483581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The prevalence of Vitiligo and its associated risk factors in the middle East and Africa: A systematic review and meta-analysis 中东和非洲的白癜风发病率及其相关风险因素:系统回顾与荟萃分析
Pub Date : 2024-06-24 DOI: 10.1016/j.hsr.2024.100187
Michael Khoury, Toufic Dabit, Hanna Siniora, Julie Fashho, Ahmad A. Toubasi

Vitiligo is a prevalent chronic autoimmune skin disorder. However, the data about its prevalence and risk factors in the Middle East (ME) and Africa is scarce. Thus, we decided to conduct a systematic review and meta-analysis to assess the prevalence and risk factors of vitiligo in the ME and African regions. On the 25th of June 2023 a systematic search of the following database: PubMed, Scopus, Web of Sciences and Cochrane was conducted. All articles were included if they were observational studies that reported the prevalence or risk factors of any type of Vitiligo in one or more ME or African countries with no restriction to the type of vitiligo, age group, or gender. The total number of the included participants was 226,115 from 38 studies. The overall prevalence of vitiligo was 3 % (95 %CI: 2 %-4 %) while the prevalence among males and females were 1 % (95 %CI: 1 %-2 %) and 1 % (95 %CI: 1 %-2 %), respectively. The prevalence among pediatrics was 2 % (95 %CI: 1 %-2 %) while it was 10 % (95 %CI: 7 %-13 %) among adults. The models showed that the prevalence of vitiligo in Africa was 3 % (95 %CI: 1 %-4 %) while the pooled prevalence of vitiligo in Arabian countries was 2 % (95 %CI: 1 %-3 %). Sub-group analysis according to the year of publication showed that the pooled prevalence before 2010 was 3 % (95 %CI: 2 %-4 %). On the other hand, the pooled prevalence after 2010 was 2 % (95 %CI: 1 %-4 %). Clinicians should pay attention to the high prevalence of vitiligo and the characteristics of vitiligo patients. Also, governmental efforts should be taken to increase the awareness about vitiligo in the ME and African countries to increase early diagnosis and management of the disease resulting in better outcomes.

白癜风是一种常见的慢性自身免疫性皮肤病。然而,有关其在中东(ME)和非洲的发病率和风险因素的数据却很少。因此,我们决定进行一次系统回顾和荟萃分析,以评估白癜风在中东和非洲地区的发病率和风险因素。2023 年 6 月 25 日,我们对以下数据库进行了系统检索:PubMed、Scopus、Web of Sciences 和 Cochrane。所有文章只要是报告了一个或多个中东部或非洲国家任何类型白癜风的发病率或风险因素的观察性研究,且不限制白癜风类型、年龄组或性别,均被收录。38项研究共纳入226 115名参与者。白癜风的总发病率为3%(95%CI:2%-4%),男性和女性的发病率分别为1%(95%CI:1%-2%)和1%(95%CI:1%-2%)。儿科患病率为 2 %(95 %CI:1 %-2 %),而成人患病率为 10 %(95 %CI:7 %-13 %)。模型显示,非洲的白癜风患病率为3%(95%CI:1%-4%),而阿拉伯国家的白癜风患病率为2%(95%CI:1%-3%)。根据发表年份进行的分组分析表明,2010年之前的总体发病率为3%(95%CI:2%-4%)。另一方面,2010 年之后的总患病率为 2%(95%CI:1%-4%)。临床医生应关注白癜风的高发病率和白癜风患者的特点。此外,政府应努力提高中东和非洲国家对白癜风的认识,以增加疾病的早期诊断和管理,从而获得更好的治疗效果。
{"title":"The prevalence of Vitiligo and its associated risk factors in the middle East and Africa: A systematic review and meta-analysis","authors":"Michael Khoury,&nbsp;Toufic Dabit,&nbsp;Hanna Siniora,&nbsp;Julie Fashho,&nbsp;Ahmad A. Toubasi","doi":"10.1016/j.hsr.2024.100187","DOIUrl":"https://doi.org/10.1016/j.hsr.2024.100187","url":null,"abstract":"<div><p>Vitiligo is a prevalent chronic autoimmune skin disorder. However, the data about its prevalence and risk factors in the Middle East (ME) and Africa is scarce. Thus, we decided to conduct a systematic review and meta-analysis to assess the prevalence and risk factors of vitiligo in the ME and African regions. On the 25th of June 2023 a systematic search of the following database: PubMed, Scopus, Web of Sciences and Cochrane was conducted. All articles were included if they were observational studies that reported the prevalence or risk factors of any type of Vitiligo in one or more ME or African countries with no restriction to the type of vitiligo, age group, or gender. The total number of the included participants was 226,115 from 38 studies. The overall prevalence of vitiligo was 3 % (95 %CI: 2 %-4 %) while the prevalence among males and females were 1 % (95 %CI: 1 %-2 %) and 1 % (95 %CI: 1 %-2 %), respectively. The prevalence among pediatrics was 2 % (95 %CI: 1 %-2 %) while it was 10 % (95 %CI: 7 %-13 %) among adults. The models showed that the prevalence of vitiligo in Africa was 3 % (95 %CI: 1 %-4 %) while the pooled prevalence of vitiligo in Arabian countries was 2 % (95 %CI: 1 %-3 %). Sub-group analysis according to the year of publication showed that the pooled prevalence before 2010 was 3 % (95 %CI: 2 %-4 %). On the other hand, the pooled prevalence after 2010 was 2 % (95 %CI: 1 %-4 %). Clinicians should pay attention to the high prevalence of vitiligo and the characteristics of vitiligo patients. Also, governmental efforts should be taken to increase the awareness about vitiligo in the ME and African countries to increase early diagnosis and management of the disease resulting in better outcomes.</p></div>","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772632024000400/pdfft?md5=1121730b9d14abfe8fa530b7aed5a0eb&pid=1-s2.0-S2772632024000400-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141540872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trim the fat, trim the risk: Can bariatric surgery prevent breast cancer? "减少脂肪,降低风险:减肥手术能预防乳腺癌吗?
Pub Date : 2024-06-15 DOI: 10.1016/j.hsr.2024.100184
Asad Gul Rao, Neha Pervez
{"title":"Trim the fat, trim the risk: Can bariatric surgery prevent breast cancer?","authors":"Asad Gul Rao,&nbsp;Neha Pervez","doi":"10.1016/j.hsr.2024.100184","DOIUrl":"10.1016/j.hsr.2024.100184","url":null,"abstract":"","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772632024000370/pdfft?md5=968b5547eba990aad477b79b7c850334&pid=1-s2.0-S2772632024000370-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141410282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human health effects associated with occupational and environmental acoustic trauma 职业和环境声创伤对人类健康的影响
Pub Date : 2024-06-10 DOI: 10.1016/j.hsr.2024.100181
Noura Gannouni , Jing Wang , Khémais Ben Rhouma , Abada Mhamdi

Noise is ubiquitous in daily life and can cause both auditory and non-auditory health problems. Noise effects involve both direct and indirect pathways through which noise affects human health. A direct pathway encompasses the interactions between the central auditory system and other regions of the brain. The indirect pathway involves the cognitive and emotional response to a noise-exposure.

This review begins by summarizing both auditory and non-auditory health effects of occupational and environmental noise exposures. It then guides the reader to adequate mitigation strategies and preventive measures to reduce the consequences of noise nuisance.

噪音在日常生活中无处不在,可造成听觉和非听觉健康问题。噪声对人体健康的影响既有直接途径,也有间接途径。直接途径包括中枢听觉系统与大脑其他区域之间的相互作用。本综述首先总结了职业和环境噪声暴露对听觉和非听觉健康的影响。然后,它将指导读者采取适当的缓解策略和预防措施,以减少噪声骚扰的后果。
{"title":"Human health effects associated with occupational and environmental acoustic trauma","authors":"Noura Gannouni ,&nbsp;Jing Wang ,&nbsp;Khémais Ben Rhouma ,&nbsp;Abada Mhamdi","doi":"10.1016/j.hsr.2024.100181","DOIUrl":"10.1016/j.hsr.2024.100181","url":null,"abstract":"<div><p>Noise is ubiquitous in daily life and can cause both auditory and non-auditory health problems. Noise effects involve both direct and indirect pathways through which noise affects human health. A direct pathway encompasses the interactions between the central auditory system and other regions of the brain. The indirect pathway involves the cognitive and emotional response to a noise-exposure.</p><p>This review begins by summarizing both auditory and non-auditory health effects of occupational and environmental noise exposures. It then guides the reader to adequate mitigation strategies and preventive measures to reduce the consequences of noise nuisance.</p></div>","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772632024000345/pdfft?md5=dd271a900242192021b6bac9275e8528&pid=1-s2.0-S2772632024000345-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141402152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
“Is tirofiban the silver bullet for early neurological deterioration in stroke?” "替罗非班是治疗中风早期神经功能恶化的银弹吗?
Pub Date : 2024-06-01 DOI: 10.1016/j.hsr.2024.100180
Asad Gul Rao
{"title":"“Is tirofiban the silver bullet for early neurological deterioration in stroke?”","authors":"Asad Gul Rao","doi":"10.1016/j.hsr.2024.100180","DOIUrl":"https://doi.org/10.1016/j.hsr.2024.100180","url":null,"abstract":"","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772632024000333/pdfft?md5=7afbb11f74c69f794d943baedb73d17b&pid=1-s2.0-S2772632024000333-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141243887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Substantial growth of Health Sciences Review 健康科学评论》大幅增长
Pub Date : 2024-06-01 DOI: 10.1016/j.hsr.2024.100182
Burcin Ekser
{"title":"Substantial growth of Health Sciences Review","authors":"Burcin Ekser","doi":"10.1016/j.hsr.2024.100182","DOIUrl":"https://doi.org/10.1016/j.hsr.2024.100182","url":null,"abstract":"","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772632024000357/pdfft?md5=7f5bd5837c1699cbb5ab067191537500&pid=1-s2.0-S2772632024000357-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141325601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Health sciences review (Oxford, England)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1